Loading provider…
Loading provider…
Neurology Physician in Tampa, FL
NPI: 1447249115Primary Practice Location
ST JOSEPHS HOSPITAL
3001 W Dr Martin Luther King Jr Blvd, Tampa, FL
Primary Employer
Neuroscience Consultants LLP
fcneurology.net
HQ Phone
Get M.D. Mark's Phone NumberMobile
Get M.D. Mark's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardFL State Medical License
FL State Medical License
1996 - 2026
NC State Medical License
1992 - 1999
ME State Medical License
1992

American Board of Psychiatry and Neurology
Neurology
Duke University Hospital
Fellowship • Clinical Neurophysiology
1995 - 1996
Residency • Neurology
1992 - 1995
MaineHealth
Internship • Internal Medicine
1991 - 1992
The Robert Larner, M.D. College of Medicine
uvm.edu
Medical School
Until 1991
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99215Established patient office or other outpatient, visit typically 40 minutes | 90 | 129 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 66 | 78 |
| 3 | 96413Infusion of chemotherapy into a vein up to 1 hour | 47 | 130 |
| 4 | 96415Infusion of chemotherapy into a vein | 40 | 112 |
| 5 | J2350Injection, ocrelizumab, 1 mg | 34 | 36,600 |
Comparative injection-site pain and tolerability of subcutaneous serum-free formulation of interferonβ-1a versus subcutaneous interferonβ-1b: results of the randomized, multicenter, Phase IIIb REFORMS study.
Authors: Daniel Bandari, Christopher Laganke, Fernando Dangond, Barry Singer
Publication Date: 2012-12
Authors: Eric Watsky, Gabriel Pardo, Fernando Dangond, Barry Singer
Journal: Mult Scler Relat Disord
Publication Date: 2012-01-20
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine
Lead Sponsor: EMD Serono Research & Development Institute, Inc.
Collaborators: Merck KGaA, Darmstadt, Germany
Intervention / Treatment: DRUG: Cladribine Tablets
Lead Sponsor: Suven Life Sciences Limited
Intervention / Treatment: DRUG: Placebo, DRUG: Memantine, DRUG: Donepezil, DRUG: SUVN-502